complete-copper-peptides The design of high specificity binders for peptide-MHC-I complexes is a rapidly advancing field, leveraging cutting-edge computational and artificial intelligence (AI) tools to create novel molecules with precise targeting capabilities作者:W Jiang·2010·被引用次数:73—Here, we report a quantitative,high-throughput methodology, yeast codisplay (Fig. 1), for characterizing and engineeringpeptide-bindingspecificityofMHC-II.. These binders are crucial for understanding and manipulating immune responses, with potential applications in immunotherapy and diagnostics.
At the forefront of this research are deep learning-based protein design tools. These sophisticated algorithms enable the de novo design of small proteins that can specifically interact with the peptide binding groove of MHC complexes.Predicting the Affinity of Peptides to Major Histocompatibility ... The goal is to create high specificity binders that can recognize and bind to particular peptide-MHC-I (pMHC-I) complexes, mimicking the specificity of T-cell receptors (TCRs) but with the advantage of engineered stability and accessibility.
Recent advancements, as highlighted in studies from 2024 and projected for 2025, demonstrate the power of these AI-driven approaches. For instance, tools like RFdiffusion have been instrumental in designing pMHC-I binding proteins that establish extensive contacts with the target peptide. This allows for the identification of highly specific binders for a multitude of pMHCs. The design process often involves computational modeling to optimize interactions, leveraging forces such as hydrogen bonding and hydrophobic interactions to achieve the desired specificity.2024年11月28日—Here we describe the use ofdeep learning-based protein design toolstode novodesign small proteins that arc above the peptide binding groove of ...
The Class I major histocompatibility complex (MHC-I) molecules play a vital role in the immune system by presenting peptides derived from intracellular antigens on the cell surface. This presentation is essential for immune surveillance, allowing T cells to identify and respond to infected or cancerous cells作者:B Liu·2025·被引用次数:29—We used RFdiffusion todesignpMHCI-binding proteins that make extensive contacts with thepeptideand identified specificbindersfor 11 target .... Aberrant presentation of these peptides by MHC complexes can lead to autoimmune diseases or failure to eliminate pathogens and tumors. Therefore, the ability to precisely target specific peptide-MHC-I complexes with engineered binders holds immense therapeutic promise.研究揭示多肽-MHC-I复合物的高特异性结合物设计 - 新闻
The design of high-specificity binders for peptide-MHC-I complexes is not just a theoretical exercise; it is being translated into practical applications作者:H Du·2024·被引用次数:17—Here, we set out to develop a de novo platform to generate pMHC Ibindersthat implements the following features: an invariant docking mode .... Researchers are developing rapid, integrated platforms to generate and validate de novo protein binders against user-defined pMHC targets. These platforms can start from experimental or predicted structures of the target pMHC complexes, offering a versatile approach to binder design. The aim is to computationally design high-affinity and high-specificity binders that can effectively modulate immune responses.
The implications of this research are far-reaching. By creating binders that mimic TCR specificity, scientists are paving the way for new immunotherapies.Design of high specificity binders for peptide-MHC-I complexes. Class I MHC molecules present peptides derived from intracellular antigens ... These engineered molecules can potentially be used to either enhance the immune system's ability to detect and destroy disease-causing cells or to dampen overactive immune responses in autoimmune conditions.Targeting peptide antigens using a multiallelic MHC I- ... The design of these specificity binders is a testament to the power of combining structural biology, computational design, and AI to address complex biological challenges.
Furthermore, the development of these high specificity binders for peptide-MHC-I complexes is contributing to a broader understanding of MHC and peptide interactions. Research into MHC and peptide binding affinity, for example, utilizes computational methods to predict how strongly different peptides will bind to specific MHC alleles. This knowledge is critical for identifying optimal peptide targets for therapeutic intervention and for designing effective binders. The ultimate aim is to create precise tools that can help immune cells spot disease with unparalleled accuracy, leading to more effective and personalized treatments. The ongoing work in this area, with numerous publications and ongoing research projects, underscores the significance and rapid progress in the design of high specificity binders for peptide-MHC-I complexes.
Join the newsletter to receive news, updates, new products and freebies in your inbox.